ArticleFrontiers in endocrinology2026
Development and validation of a predictive model for early blastocyst formation on day 4 post-fertilization.
Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Glycine as a Metabolic Regulator of Reproductive Function in Livestock: From Gametes to Early Embryos.Animals : an open access journal from MDPI · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To develop and validate a predictive model for early blastocyst formation on Day 4 post-fertilization using clinically accessible parameters. Methods: This retrospective cohort of 2,557 patients scheduled for fresh Day 4 embryo transfer was randomly divided into training (n=1,789) and validation (n=768) sets at Xingtai MeiHe Reproductive and Genetic Hospital from January 2021 to December 2025. Early blastocyst formation occurred in 44.9% (training) and 44.1% (validation) of cases. Multivariable logistic regression and nomogram modeling were employed, with model performance assessed via AUC, calibration curves, and decision curve analysis. Results: After multivariable adjustment, the number of Day 3 embryos with >10 blastomeres (aOR=1.668, 95% CI: 1.374~2.025, P<0.001) and those with iDAScore >4.8 (aOR=1.369, 95% CI: 1.190 ~ 1.575, P<0.001) were the only independent predictors of Day 4 early blastocyst formation, while 15 covariates including ovarian reserve markers and sperm parameters showed no significant association (P>0.05). The nomogram integrating Day 3 embryos with >10 blastomeres and iDAScore>4.8 demonstrated robust discrimination (training AUC = 0.782, 95% CI: 0.738 ~ 0.826; validation AUC = 0.773, 95% CI: 0.705 ~ 0.841) with sensitivity of 65.4~65.9% and specificity of 79.6 ~ 81.7%. Calibration curves indicated minimal prediction deviation, and decision curve analysis confirmed clinical net benefits across 18~80% threshold probabilities in the training cohort and 20~93% in the validation cohort. Clinically, early blastocyst formation was associated with superior embryo quality parameters (P<0.001), higher single embryo transfer rates (50.90% vs. 13.96%, P<0.001), and increased clinical (67.65% vs. 59.32%, P<0.001) and ongoing pregnancy rates (59.59% vs. 52.89%, P = 0.006), alongside a lower multiple pregnancy rate (22.50% vs. 31.93%, P<0.001). Multivariable regression confirmed early blastocyst formation as an independent predictor of pregnancy success (clinical pregnancy aOR=1.675, 95% CI: 1.287 ~ 2.180, P<0.001; ongoing pregnancy aOR=1.612, 95% CI: 1.249 ~ 2.080, P<0.001). Conclusion: The validated nomogram accurately predicts Day 4 early blastocyst formation using Day 3 embryo parameters. The presence of early blastocyst formation on Day 4 might indicate suitability for selective Day 4 embryo transfer.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.